Incorporating a social responsibility goal in the prompt causes overleverage in utilities (A) and decreases risk of low ESG rating (B) (Study 3). by Philipp Winder (21615570)

Overview of the six original ACTIV-3/TICO trials. by Elizabeth S. Munroe (21568166)

A summary of the included study characteristics. by Zahra Tajik (20752452)

“…The results show that one month after the NSPT, there was no significant difference in the mean visfatin level of GCF (SMD: -3.91, 95%CI: -9.83, 2.01, p = 0.195, I-square, 96.6%, random effect model, n = 2) and serum (SMD: -0.33, 95%CI: -0.98, 0.33, p = 0.332, fixed effect model, n = 1), but 2, 3 and 6 months after NSPT, the mean visfatin level of GCF and serum decreased significantly. There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”

Data from: Colony losses of stingless bees increase in agricultural areas, but decrease in forested areas by Malena Sibaja Leyton (18400983)

“…</p><p><br></p><p dir="ltr">The data are related to the scientific paper “Sibaja Leyton M. et al., (under review) Colony losses of stingless bees increase in agricultural areas, but decrease in forested areas”.</p><p dir="ltr">Data are available as a csv file titled:</p><p dir="ltr">"Sibaja_Leyton_et_al_Dataset_Stingless_Bee_Colony_Losses_in_Latin_America.csv".…”

Data Sheet 1_Early caffeine therapy decreases bronchopulmonary dysplasia but might increase mortality in preterm infants? a systematic review and meta-analysis.docx by Juan Ma (417126)

Data Sheet 2_Early caffeine therapy decreases bronchopulmonary dysplasia but might increase mortality in preterm infants? a systematic review and meta-analysis.docx by Juan Ma (417126)

The forest plots of the effect of probiotics on the level of T-reg (A) and CD4 CD25 (B). by Zahra Zangeneh (11772967)

The forest plots of the effect of probiotics on the level of IFN-γ by ELISA (A) and RT-PCR (B) methods. by Zahra Zangeneh (11772967)

The forest plots of the effect of probiotics on the level of TNF-α by ELISA (A) and RT-PCR (B) methods. by Zahra Zangeneh (11772967)

The forest plots of the effect of probiotics on the level of IL-10 by ELISA (A) and RT-PCR (B) methods. by Zahra Zangeneh (11772967)

The forest plots of the effect of probiotics on the level of IL-17 by ELISA (A), RT-PCR (B) and Flow cytometry (C) methods. by Zahra Zangeneh (11772967)

The forest plots of the effect of probiotics in human studies on the level of IFN-γ (A), IL-17 (B), and TNF-α (C). by Zahra Zangeneh (11772967)

Mean amplitude values during a complete 360° rotation for the iliocostalis muscle. by Christoph Anders (4068499)

Mean amplitude values during a complete 360° rotation for the longissimus muscle. by Christoph Anders (4068499)

Mean amplitude values during a complete 360° rotation for the multifidus muscle. by Christoph Anders (4068499)

Mean amplitude values during a complete 360° rotation for the external oblique muscle. by Christoph Anders (4068499)

Mean amplitude values during a complete 360° rotation for the internal oblique muscle. by Christoph Anders (4068499)

Mean amplitude values during a complete 360° rotation for the rectus abdominis muscle. by Christoph Anders (4068499)

Bidimensional High-Low Frequency (HF, LF) plane representation of the interaction among Phase and High-Low Clarity Groups_: In the Low Clarity (LC) group there was a larg... by David Vagni (8060432)

List of Included studies. by Zahra Tajik (20752452)

“…The results show that one month after the NSPT, there was no significant difference in the mean visfatin level of GCF (SMD: -3.91, 95%CI: -9.83, 2.01, p = 0.195, I-square, 96.6%, random effect model, n = 2) and serum (SMD: -0.33, 95%CI: -0.98, 0.33, p = 0.332, fixed effect model, n = 1), but 2, 3 and 6 months after NSPT, the mean visfatin level of GCF and serum decreased significantly. There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”